Detalhe da pesquisa
1.
Comparison of different laboratory tests in the evaluation of hemorrhagic risk of patients using rivaroxaban in the critical care setting: diagnostic accuracy study.
Thromb J;
15: 21, 2017.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28814943
2.
Highlights from the fifth international symposium of thrombosis and anticoagulation (ISTA V), October 18-19, 2012, Belo Horizonte, Minas Gerais, Brazil.
J Thromb Thrombolysis;
36(1): 115-30, 2013 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23494487
3.
Rivaroxaban Versus Enoxaparin for Thromboprophylaxis After major Gynecological Cancer Surgery: The VALERIA Trial : Venous thromboembolism prophylAxis after gynecoLogical pElvic cancer surgery with RIvaroxaban versus enoxAparin (VALERIA trial).
Clin Appl Thromb Hemost;
28: 10760296221132556, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36474344
4.
Rediscussing Anticoagulation in Distal Deep Venous Thrombosis.
Clin Appl Thromb Hemost;
22(8): 772-778, 2016 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26787712
5.
Risk of asymptomatic pulmonary embolism in patients with deep venous thrombosis.
J Vasc Surg Venous Lymphat Disord;
1(4): 370-5, 2013 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26992758